Obrin Eye Drop contains Tobramycin 0.3% w/v, an aminoglycoside antibiotic effective against a broad spectrum of gram-negative and some gram-positive bacteria. It is primarily indicated for the treatment of bacterial infections of the eye, including conjunctivitis, keratitis, blepharitis, and other superficial ocular infections caused by susceptible organisms. Tobramycin exerts its antibacterial effect by binding to the 30S ribosomal subunit, inhibiting protein synthesis and ultimately leading to bacterial cell death. Obrin Eye Drop is administered topically, allowing for high local concentrations at the site of infection while minimizing systemic exposure. The recommended dosage typically involves instilling one or two drops into the affected eye every four to six hours, with adjustments based on the severity of the infection and clinical response. Patients should be advised to avoid contaminating the dropper tip and to discontinue use if hypersensitivity or irritation occurs. Caution is advised in patients with known hypersensitivity to aminoglycosides. Use during pregnancy and lactation should be under medical supervision. Obrin Eye Drop is a valuable therapeutic option for managing bacterial ocular infections, promoting rapid resolution and preventing complications associated with untreated eye infections.